Newsletter
Get Healthcare AI Briefings
Monthly procurement notes on clinical AI categories, validation, compliance, and vendor changes.
Cardiac CT analysis tools for coronary artery disease assessment.
HeartFlow provides coronary artery disease assessment tools using cardiac CT data to support non-invasive heart disease evaluation and care planning.
Reliability of claims, output quality, and evidence fit.
Fit for clinical, revenue, or operations workflows.
HIPAA, PHI, BAA, and governance readiness signals.
Value relative to expected cost, onboarding, and effort.
Maturity, documentation, support, and market signals.
This review has not published a long-form introduction yet.
Not publicly listed; verify contract terms, reimbursement assumptions, and deployment scope.
HIPAA
Not reviewed
BAA
Not reviewed
Verify intended use, applicable regulatory status, image data transfer, BAA terms, clinician review workflow, integration with cardiology operations, and audit controls.
HealthAIdir used vendor public materials for this seed profile. No vendor paid for placement, and buyers should verify all compliance, pricing, and implementation claims directly with HeartFlow.
Featured or sponsor placement does not affect HealthAIdir scores, verdicts, comparisons, or editorial recommendations.
Evidence: HeartFlow official site describes coronary artery disease assessment products that use cardiac CT data. Sources: https://www.heartflow.com/